724 filings
SC 13D/A
Raymond J. Bartoszek
2 May 24
KINETA / Bartoszek Raymond J. ownership change
4:39pm
4
Raymond J. Bartoszek
2 May 24
KINETA / Raymond J. Bartoszek ownership change
4:36pm
ARS
2023 FY
KA
Kineta Inc
26 Apr 24
Annual report to shareholders
4:06pm
DEFA14A
KA
Kineta Inc
26 Apr 24
Additional proxy soliciting materials
4:03pm
DEF 14A
KA
Kineta Inc
Definitive proxy
26 Apr 24
4:00pm
8-K
KA
Kineta Inc
24 Apr 24
Entry into a Material Definitive Agreement
4:00pm
8-K
KA
Kineta Inc
18 Apr 24
Departure of Directors or Certain Officers
4:00pm
4
Shawn Iadonato
16 Apr 24
KINETA / Shawn Iadonato ownership change
5:04pm
4
KA
Kineta Inc
16 Apr 24
KINETA / CRAIG W. PHILIPS ownership change
5:02pm
4
Keith Baker
16 Apr 24
KINETA / Keith Baker ownership change
5:01pm
4
Thierry Guillaudeux
16 Apr 24
KINETA / Thierry Guillaudeux ownership change
4:59pm
8-K
KA
Kineta Inc
8 Apr 24
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
4:02pm
10-K
2023 FY
KA
Kineta Inc
Annual report
21 Mar 24
4:06pm
8-K
KA
Kineta Inc
21 Mar 24
Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update
4:04pm
8-K
KA
Kineta Inc
12 Mar 24
Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts
8:05am
8-K
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
SC 13G
Armistice Capital, LLC
14 Feb 24
KINETA / ARMISTICE CAPITAL ownership change
3:40pm
SC 13D/A
Shawn Iadonato
12 Feb 24
KINETA / Iadonato Shawn ownership change
4:05pm
SC 13G/A
Magness Charles
12 Feb 24
KINETA / Magness Charles ownership change
4:05pm
8-K
KA
Kineta Inc
17 Jan 24
Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors
8:30am